YARW
Yarrow Bioscience Inc
20.30$
-8.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +100.9% | -0.2% | +0.0% | +102.4% | +205.3% | -82.1% | +1,940.8% | – | – | – | – | – | – | – | +567.9% | -72.0% | +31.1% | -94.6% | +28.3% | -54.9% | +1,623.3% | -92.2% | -29.2% | +32.5% | -96.4% | +1,550.0% | +36.4% | -15.6% | -33.3% | +28.9% | +102.0% | -38.9% | -30.6% | +140.5% | -65.8% | +144.9% | -23.1% | -33.8% | +12.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -20.3% | +71.8% | +43.9% | – | – | +0.0% | +3,125.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | – | -0.2% | +0.0% | +102.4% | +205.3% | -82.1% | +1,940.8% | – | – | – | – | – | – | – | +675.7% | -74.7% | +29.5% | -93.9% | +16.1% | -60.7% | +1,222.9% | -87.2% | -29.2% | +32.5% | -96.4% | +1,550.0% | +36.4% | -15.6% | -33.3% | +28.9% | +102.0% | -38.9% | -30.6% | +140.5% | -65.8% | +144.9% | -23.1% | -38.5% | +13.7% | – | |
| – | +43.0% | +22.4% | +9.4% | +46.7% | +31.7% | +4.5% | +47.2% | -34.3% | +41.3% | +5.6% | -15.5% | -6.2% | -6.8% | +35.7% | -17.8% | -49.5% | +18.3% | -45.7% | +18.6% | +17.2% | -11.5% | -15.0% | -7.7% | +35.0% | -22.8% | -36.1% | +164.6% | -54.1% | -8.9% | +22.7% | +97.0% | +40.3% | -5.5% | -36.8% | -20.3% | +7.7% | -43.4% | -72.6% | -3.5% | – | |
| – | – | -22.0% | +20.0% | +1.8% | +38.0% | +58.1% | +14.6% | -1.8% | +10.8% | +11.4% | +0.3% | +27.8% | +111.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12.8% | -9.9% | +7.0% | +3.3% | -16.6% | -0.9% | -12.3% | +29.8% | -21.7% | – | |
| – | +45.4% | +11.7% | +11.2% | +38.5% | +32.5% | +12.0% | +40.8% | -29.1% | +34.6% | +6.7% | -12.5% | +1.2% | +25.8% | +88.6% | +331.9% | -111.5% | – | – | -1.8% | +10.8% | -198.0% | – | -5.1% | +12.9% | -15.9% | -25.2% | +75.0% | -39.3% | +8.8% | +8.3% | +41.7% | +24.7% | -2.7% | -26.9% | -19.0% | +4.6% | -32.8% | -27.2% | -18.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,956.5% | -102.0% | – | – | – | -172.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -22.7% | -22.2% | +141.4% | +0.1% | +14.3% | -11.6% | -2.0% | +1.1% | +223.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -281.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.